Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / G.I. and Other Associated Cancers Research Group / Developed the first EDRN large, multi-center cross-sectional trial of biomarkers for the early detection of hepatocellular carcinoma (HCC)

Developed the first EDRN large, multi-center cross-sectional trial of biomarkers for the early detection of hepatocellular carcinoma (HCC)

Demonstrated that des-carboxyprothrombin (DCP) has a significant advantage over AFP for detecting HCC with viral etiology

Announcement 10/27/2016

Thank you to everyone who contributed to the successful and productive EDRN Orientation Meeting in October. The next EDRN Steering Committee Meeting will take place in March 6-9, 2017 in Tempe, AZ. More information about this meeting will be available soon.

Announcement